Brind.

Clement Fourny appointed CEO of Biodextris, a former GSK development center

1 report, 1 independent Updated Sep 28
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Biodextris, a biologics contract development and manufacturing organization (CDMO) based in Laval, Quebec, announced the appointment of Clement Fourny as its Chief Executive Officer. Biodextris originated as a biologics development center for GSK and specializes in working with complex biologics.

From chathamdailynews.ca

Why it matters

Some supportBrind's analysis of the reports

Fourny brings over two decades of commercial and financial leadership experience across the life sciences sector. His expertise is expected to position Biodextris to capture growing demand for specialized bio-manufacturing services across North America.

From chathamdailynews.ca

Who's involved

  • GSKGSK was the company from which Biodextris originated as a biologics development center.
  • SmartLabsClement Fourny previously served as Senior Vice President, Commercial at SmartLabs.
  • CytivaClement Fourny previously served as General Manager, Commercial Operations & Strategy at Cytiva.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped